Previous 10 | Next 10 |
Ekso Bionics Holdings, Inc. (EKSO) Q1 2021 Earnings Conference Call April 29, 2021 4:30 p.m. ET Company Participants Matt Steinberg - Investor Relations-Lazar Finn Partners Jack Peurach - President and CEO Jack Glenn - CFO Bill Shaw - Chief Commercial Officer Conference Call Participants RK -...
Ekso Bionics Holdings (EKSO): Q1 GAAP EPS of -$0.34 misses by $0.10.Revenue of $1.91M (+29.9% Y/Y) misses by $1.09M.Gross margins of ~65%, compared to 43% in the same period of 2020.Shares +2.5%.Press Release For further details see: Ekso Bionics Holdings EPS misses by $0.10, misses on ...
RICHMOND, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2021. Rec...
RICHMOND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2021 after the close of tra...
Gainers: Ardelyx (ARDX) +13%, Liquidia (LQDA) +9%, PPD (PPD) +7%, Inovio Pharmaceuticals (INO) +6%, BiomX (PHGE) +6%.Losers: Zomedica (ZOM) -12%, Affimed (AFMD) -10%, Aesthetic Medical International (AIH) -7%, Galectin Therapeut...
The following slide deck was published by Ekso Bionics Holdings, Inc. in conjunction with this event. For further details see: Ekso Bionics (EKSO) Presents At H.C. Wainwright Global Life Sciences Conference
RICHMOND, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced a partnership with U.S. Physiatry (USP) to educate physicians on the cl...
RICHMOND, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Performance Contracting, Inc. (“PCI”), a leading U.S...
RICHMOND, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright Global Life Sciences Co...
Ekso Bionics Holdings, Inc. (EKSO) Q4 2020 Earnings Conference Call February 25, 2020 4:30 PM ET Company Participants Matt Steinberg – Investor Relations-Lazar Finn Partners Jack Peurach – President and Chief Executive Officer Bill Shaw – Chief Commercial Officer Jack Gle...
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Ekso Bionics Holdings Inc. Website:
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2...
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”...